Insider · CIK 0001727727

Hadar Ilan

Reports to the SEC for 3 companies · RAMAT GAN

sec.gov

Transactions

Companies

Filings

CIK

0001727727

Forms 4 and 5

Insider transactions

38 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-04	SLXNSilexion Therapeutics CorpA Award	Director, Chairman and CEO	AAward	+10K sh	—	—	16,547
2026-02-20	SLXNSilexion Therapeutics CorpA Award	Director, Chairman and CEO	AAward	+64.4K sh	—	—	65,471
2020-03-09	YARWYarrow Bioscience, Inc. · Stock OptionsA Award	CFO and Country Manager	AAward	+3,239 sh	—	—	3,239
2020-03-09	YARWYarrow Bioscience, Inc. · Stock OptionsA Award	CFO and Country Manager	AAward	+14.3K sh	—	—	14,291
2020-03-09	YARWYarrow Bioscience, Inc. · Stock OptionsA Award	CFO and Country Manager	AAward	+10.7K sh	—	—	10,663
2020-03-09	YARWYarrow Bioscience, Inc. · Stock OptionsA Award	CFO and Country Manager	AAward	+120K sh	—	—	119,667
2020-03-09	YARWYarrow Bioscience, Inc. · Stock OptionsA Award	CFO and Country Manager	AAward	+35.5K sh	—	—	35,544
2020-03-09	YARWYarrow Bioscience, Inc. · Stock OptionsA Award	CFO and Country Manager	AAward	+35.8K sh	—	—	35,774
2020-03-09	YARWYarrow Bioscience, Inc. · Stock OptionsA Award	CFO and Country Manager	AAward	+116K sh	—	—	116,231
2020-03-09	YARWYarrow Bioscience, Inc. · Stock OptionsA Award	CFO and Country Manager	AAward	+20.8K sh	—	—	20,789
2020-03-09	YARWYarrow Bioscience, Inc. · Stock OptionsA Award	CFO and Country Manager	AAward	+56.3K sh	—	—	56,275
2020-03-09	YARWYarrow Bioscience, Inc. · Stock OptionsA Award	CFO and Country Manager	AAward	+57.1K sh	—	—	57,086
2020-03-09	Foamix Pharmaceuticals Ltd.D Disposition to Issuer	CFO & Country Manager	DDisposition to Issuer	−14.1K sh	—	—	116,501
2020-03-09	Foamix Pharmaceuticals Ltd.D Disposition to Issuer	CFO & Country Manager	DDisposition to Issuer	−117K sh	—	—	0
2020-03-09	Foamix Pharmaceuticals Ltd.OptionsD Disposition to Issuer	CFO & Country Manager	DDisposition to Issuer	−5,469 sh	—	—	0
2020-03-09	Foamix Pharmaceuticals Ltd.OptionsD Disposition to Issuer	CFO & Country Manager	DDisposition to Issuer	−24.1K sh	—	—	0
2020-03-09	Foamix Pharmaceuticals Ltd.OptionsD Disposition to Issuer	CFO & Country Manager	DDisposition to Issuer	−18K sh	—	—	0
2020-03-09	Foamix Pharmaceuticals Ltd.OptionsD Disposition to Issuer	CFO & Country Manager	DDisposition to Issuer	−202K sh	—	—	0
2020-03-09	Foamix Pharmaceuticals Ltd.OptionsD Disposition to Issuer	CFO & Country Manager	DDisposition to Issuer	−60K sh	—	—	0
2020-03-09	YARWYarrow Bioscience, Inc.A Award	CFO and Country Manager	AAward	+8,339 sh	—	—	8,339
2020-03-09	Foamix Pharmaceuticals Ltd.OptionsD Disposition to Issuer	CFO & Country Manager	DDisposition to Issuer	−196K sh	—	—	0
2020-03-09	Foamix Pharmaceuticals Ltd.OptionsD Disposition to Issuer	CFO & Country Manager	DDisposition to Issuer	−35.1K sh	—	—	0
2020-03-09	Foamix Pharmaceuticals Ltd.OptionsD Disposition to Issuer	CFO & Country Manager	DDisposition to Issuer	−95K sh	—	—	0
2020-03-09	Foamix Pharmaceuticals Ltd.OptionsD Disposition to Issuer	CFO & Country Manager	DDisposition to Issuer	−96.4K sh	—	—	0
2020-03-09	Foamix Pharmaceuticals Ltd.OptionsD Disposition to Issuer	CFO & Country Manager	DDisposition to Issuer	−60.4K sh	—	—	0
2020-03-09	YARWYarrow Bioscience, Inc.A Award	CFO and Country Manager	AAward	+69K sh	—	—	77,351
2020-02-24	Foamix Pharmaceuticals Ltd.A Award	CFO & Country Manager	AAward	+41.3K sh	—	—	130,578
2020-02-24	Foamix Pharmaceuticals Ltd.OptionsA Award	CFO & Country Manager	AAward	+96.4K sh	—	—	96,365
2019-09-10	Foamix Pharmaceuticals Ltd.S Sale	CFO & Country Manager	SSale	−34.4K sh	$3.50	−$120K	89,279
2019-09-09	Foamix Pharmaceuticals Ltd.S Sale	CFO & Country Manager	SSale	−9,420 sh	$3.50	−$33K	123,671
2019-01-01	Foamix Pharmaceuticals Ltd.A Award	CFO & Country Manager	AAward	+40.7K sh	—	—	133,091
2019-01-01	Foamix Pharmaceuticals Ltd.Option (right to buy)A Award	CFO & Country Manager	AAward	+95K sh	$3.81	+$362K	94,996
2018-02-27	Foamix Pharmaceuticals Ltd.A Award	CFO & Country Manager	AAward	+11.7K sh	—	—	92,379
2018-02-27	Foamix Pharmaceuticals Ltd.OptionsA Award	CFO & Country Manager	AAward	+35.1K sh	$6.40	+$225K	35,093
2018-01-15	Foamix Pharmaceuticals Ltd.M Exercise/Conversion	CFO & Country Manager	MExercise/Conversion	+562 sh	—	—	80,681
2018-01-15	Foamix Pharmaceuticals Ltd.Restricted Share UnitsM Exercise/Conversion	CFO & Country Manager	MExercise/Conversion	−562 sh	—	—	0
2018-01-01	Foamix Pharmaceuticals Ltd.M Exercise/Conversion	CFO & Country Manager	MExercise/Conversion	+5,032 sh	—	—	80,681
2018-01-01	Foamix Pharmaceuticals Ltd.Restricted Share UnitsM Exercise/Conversion	CFO & Country Manager	MExercise/Conversion	−5,032 sh	—	—	0

Recent filings

Accepted (ET)
Jun 84
Hadar Ilan0001178913-26-003132
SEC(opens sec.gov)
Feb 234
Hadar Ilan0001178913-26-000600
SEC(opens sec.gov)
Mar 114
Hadar Ilan0001209191-20-018225
SEC(opens sec.gov)
Mar 114
Hadar Ilan0001209191-20-018195
SEC(opens sec.gov)

Companies

Address

C/O SILEXION THERAPEUTICS CORP 12 ABBA HILLEL ROAD

RAMAT GAN, 5250606